A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/00 (2006.01) A61K 38/17 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2529742
Methods of treating cancer and/or reducing or inhibiting tumor growth in a subject in need thereof, comprising administering pharmaceutical composition comprising a vascular endothelial cell growth factor (VEGF) antagonist, such as a VEGF trap, an anti-proliferative agent, such as taxol, and a pharmaceutically acceptable carrier.
La présente invention concerne des procédés permettant de traiter et/ou réduire ou inhiber la croissance tumorale chez un sujet qui en a besoin, selon lequel on administre une composition pharmaceutique comprenant un antagoniste du facteur de croissance des cellules de l'endothélium vasculaire (VEGF), tel qu'un VEGF Trap, un agent anti-prolifératif, tel que le taxol, et un excipient pharmaceutiquement acceptable.
Holash Jocelyn
Hu Limin
Jaffe Robert
Yancopoulos George D.
Blake Cassels & Graydon Llp
Regeneron Pharmaceuticals Inc.
The Regents Of The University Of California
LandOfFree
Composition of a vegf antagonist and an anti-proliferative... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition of a vegf antagonist and an anti-proliferative..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition of a vegf antagonist and an anti-proliferative... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1974457